SCHEMBL6265129

SCHEMBL6265129

CC(CCO)n1ccnc1

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
KMT2A Q03164 2/20 0.44
CYP19A1 P11511 1/20 0.39
CYP17A1 P05093 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28185835 0.89 KDM4E (0.46) KDM4EKMT2ACYP19A1CYP17A1
SCHEMBL3307573 0.83
SCHEMBL9459746 0.83
SCHEMBL9459911 0.83
SCHEMBL25067255 0.82 KDM4E (0.45) KDM4EKMT2ACYP19A1CYP17A1
SCHEMBL571582 0.82 CYP17A1 (0.47) KDM4EKMT2ACYP19A1CYP17A1
SCHEMBL17598731 0.82 CYP17A1 (0.47) KDM4EKMT2ACYP19A1CYP17A1
SCHEMBL27742029 0.82 CYP17A1 (0.47) KDM4EKMT2ACYP19A1CYP17A1
SCHEMBL4950866 0.80 KDM4E (0.44) KDM4EKMT2ACYP19A1CYP17A1
SCHEMBL14420588 0.80 KDM4E (0.44) KDM4EKMT2ACYP19A1CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107427758-A Utilize the separation of ion liquid solvent 切弗朗菲利浦化学公司 2017-12-01 CN claimed
EP-1000620-B1 Lp(a)-LOWERING AGENTS AND APOPROTEIN (a) PRODUCTION INHIBITORS TAIHO PHARMACEUTICAL CO LTD (JP) 2005-12-07 EP disclosed
US-6166036-A Lp(a)-lowering agent and apolipoprotein (a) formation suppressing agent TAIHO PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-1000620-A1 Lp(a)-LOWERING AGENTS AND APOPROTEIN (a) PRODUCTION INHIBTORS TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 2000-05-17 EP disclosed
US-5145865-A Fatty acid, cholesterol synthesis inhibitors; enzyme inhibitors; antilipemic agents OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1992-09-08 US disclosed